Peri implant soft and soft tissue changes around nanopore surface implants with or without platelet rich fibrin (PRF): a clinico-radiographic study

Not Applicable

Completed

• Conditions: Health Condition 1: null- Patients requiring replacement of teeth with implants

• Registration Number: CTRI/2017/10/010196
• Lead Sponsor: Saraswati Dental College Lucknow

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-12-05
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 14

Inclusion Criteria

1) Patient aged more than 18 years who could read, understand and were willing to comply with all the study related procedure after signing an informed consent statement.

2) Systemically healthy subjects having monoradicular tooth as seen in IOPA radiograph indicated for extraction. However, final decision for inclusion in the study was taken after atraumatic extraction.

3) Residual extraction socket possessing intact bone in all dimension (four wall bony defect), jumping gap less than 2 mm (confirmed during surgical phase) and occlusion suitable for planned prosthodontic treatment.

4) Patient who were nonsmoker or had quit smoking from past 2 months (self-reported).

5) The subject sample consisted of patients who required extraction of single rooted tooth and restoration by means of dental implants.

6) The reason for tooth extraction and immediate implant placement were trauma, endodontic and non-restorable carious lesion combined with root or crown fracture.

7) No tooth was removed because of advanced periodontal disease.

Exclusion Criteria

1) Pregnant women or nursing mother and patients using tobacco (smoke/smokeless).

2) Patients with clinically significant or unstable systematic disease affecting bone or soft tissue growth or other renal hepatic, cardiac, endocrine, hematologic, autoimmune, acute or acute infectious disease that contraindicate periodontal surgery .

3) Patients on antibiotic chemotherapeutics, bisphosphonate, allergy, steroid, hormone contraceptives and any other drugs that can effects the bone turn over or immune â?? inflammatory response in last 6 months.

4) Presence of any chronic systemic disease (example diabetes mellitus), allergy, immuno-suppression, previous history of hospitalization in one year, ongoing chemo/radiotherapy or a history of drug abuse.

5) Presence of chronic pain, purulent periodontal and endodontic lesion as well as severe periodontal bone loss with a remaining alveolar height of less than 7mm.

Study & Design

• Study Type: Interventional
• Study Design: Not specified